Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud(Saarland University), Michael Böhm(Saarland University), Pamela McKenna(Medtronic (United States)), Stuart Pocock(University of London), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Sebastian Ewen(Saarland University), Michael A. Weber(SUNY Downstate Health Sciences University), Antony Walton, Raymond R. Townsend(University of Pennsylvania), Roland E. Schmieder, Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Kyriakos Dimitriadis(National and Kapodistrian University of Athens), Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(Hippocration General Hospital), David E. Kandzari(Piedmont Atlanta Hospital), Richard D’Souza(Royal Devon and Exeter Hospital), Ingrid Hopper(The Alfred Hospital), Sandeep Brar(Medtronic (United States)), Andrew Sharp(University Hospital of Wales), Kazuomi Kario(Jichi Medical University)
The Lancet
April 1, 2022
Cited by 282


Related Papers